263 related articles for article (PubMed ID: 31309709)
21. Genetic pharmacology: progresses in siRNA delivery and therapeutic applications.
Scherman D; Rousseau A; Bigey P; Escriou V
Gene Ther; 2017 Mar; 24(3):151-156. PubMed ID: 28121307
[TBL] [Abstract][Full Text] [Related]
22. Ultra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer Efficacy.
Xu X; Wu J; Liu Y; Yu M; Zhao L; Zhu X; Bhasin S; Li Q; Ha E; Shi J; Farokhzad OC
Angew Chem Int Ed Engl; 2016 Jun; 55(25):7091-7094. PubMed ID: 27140428
[TBL] [Abstract][Full Text] [Related]
23. Amphiphilic polyallylamine based polymeric micelles for siRNA delivery to the gastrointestinal tract: in vitro investigations.
Guo J; O'Mahony AM; Cheng WP; O'Driscoll CM
Int J Pharm; 2013 Apr; 447(1-2):150-7. PubMed ID: 23467082
[TBL] [Abstract][Full Text] [Related]
24. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
[TBL] [Abstract][Full Text] [Related]
25. Lipid-Based Nanocarriers for RNA Delivery.
Xue HY; Guo P; Wen WC; Wong HL
Curr Pharm Des; 2015; 21(22):3140-7. PubMed ID: 26027572
[TBL] [Abstract][Full Text] [Related]
26. Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.
Van Woensel M; Wauthoz N; Rosière R; Mathieu V; Kiss R; Lefranc F; Steelant B; Dilissen E; Van Gool SW; Mathivet T; Gerhardt H; Amighi K; De Vleeschouwer S
J Control Release; 2016 Apr; 227():71-81. PubMed ID: 26902800
[TBL] [Abstract][Full Text] [Related]
27. Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.
Kriegel C; Attarwala H; Amiji M
Adv Drug Deliv Rev; 2013 Jun; 65(6):891-901. PubMed ID: 23220324
[TBL] [Abstract][Full Text] [Related]
28. Bridging small interfering RNA with giant therapeutic outcomes using nanometric liposomes.
Singh Y; Tomar S; Khan S; Meher JG; Pawar VK; Raval K; Sharma K; Singh PK; Chaurasia M; Surendar Reddy B; Chourasia MK
J Control Release; 2015 Dec; 220(Pt A):368-387. PubMed ID: 26528900
[TBL] [Abstract][Full Text] [Related]
29. Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo.
Zhang QY; Ho PY; Tu MJ; Jilek JL; Chen QX; Zeng S; Yu AM
Int J Pharm; 2018 Aug; 547(1-2):537-544. PubMed ID: 29894758
[TBL] [Abstract][Full Text] [Related]
30. Captopril-polyethyleneimine conjugate modified gold nanoparticles for co-delivery of drug and gene in anti-angiogenesis breast cancer therapy.
Li M; Li Y; Huang X; Lu X
J Biomater Sci Polym Ed; 2015; 26(13):813-27. PubMed ID: 26166244
[TBL] [Abstract][Full Text] [Related]
31. Peptide-based targeted polymeric nanoparticles for siRNA delivery.
Hussein WM; Cheong YS; Liu C; Liu G; Begum AA; Attallah MA; Moyle PM; Torchilin VP; Smith R; Toth I
Nanotechnology; 2019 Oct; 30(41):415604. PubMed ID: 31295734
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of novel albumin-sericin nanoparticles as siRNA delivery vehicle for laryngeal cancer treatment.
Yalcin E; Kara G; Celik E; Pinarli FA; Saylam G; Sucularli C; Ozturk S; Yilmaz E; Bayir O; Korkmaz MH; Denkbas EB
Prep Biochem Biotechnol; 2019; 49(7):659-670. PubMed ID: 31066619
[TBL] [Abstract][Full Text] [Related]
33. Small Delivery Vehicles of siRNA for Enhanced Cancer Targeting.
Kim HJ; Yi Y; Kim A; Miyata K
Biomacromolecules; 2018 Jul; 19(7):2377-2390. PubMed ID: 29864287
[TBL] [Abstract][Full Text] [Related]
34. Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.
Wilson DS; Dalmasso G; Wang L; Sitaraman SV; Merlin D; Murthy N
Nat Mater; 2010 Nov; 9(11):923-8. PubMed ID: 20935658
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in siRNA delivery.
Sarisozen C; Salzano G; Torchilin VP
Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
[TBL] [Abstract][Full Text] [Related]
36. Triggered RNAi Therapy Using Metal Inorganic Nanovectors.
Villar-Alvarez E; Leal BH; Cambón A; Pardo A; Martínez-Gonzalez R; Fernández-Vega J; Al-Qadi S; Mosquera VX; Bouzas A; Barbosa S; Taboada P
Mol Pharm; 2019 Aug; 16(8):3374-3385. PubMed ID: 31188622
[TBL] [Abstract][Full Text] [Related]
37. Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA.
Beloor J; Choi CS; Nam HY; Park M; Kim SH; Jackson A; Lee KY; Kim SW; Kumar P; Lee SK
Biomaterials; 2012 Feb; 33(5):1640-50. PubMed ID: 22112761
[TBL] [Abstract][Full Text] [Related]
38. [Application of atelocollagen-mediated siRNA delivery for RNAi therapies].
Honma K; Takeshita F; Ochiya T
Yakugaku Zasshi; 2007 May; 127(5):807-12. PubMed ID: 17473522
[TBL] [Abstract][Full Text] [Related]
39. Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract.
Ball RL; Bajaj P; Whitehead KA
Sci Rep; 2018 Feb; 8(1):2178. PubMed ID: 29391566
[TBL] [Abstract][Full Text] [Related]
40. Generation of siRNA Nanosheets for Efficient RNA Interference.
Kim H; Lee JS; Lee JB
Sci Rep; 2016 Apr; 6():25146. PubMed ID: 27120975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]